The Current Advancement and Technology in Head and Neck Cancer

Submission Deadline: 31 March 2025 View: 161 Submit to Special Issue

Guest Editors

Dr. Ahmed Hussain

E-mail: amhussai@ualberta.ca   

Affiliation: Faculty of Medicine & Dentistry - Dentistry Department, University of Alberta, Edmonton, Alberta, T6G 2R3, Canada

Homepage:  

Research Interests: Oral medicine, Oral cancer, Diagnostic techniques, Targeted therapies

Dr. Hamid Tebyaniyan

E-mail: tebyan.hamid@yahoo.com   

Affiliation: Islamic Azad University, Tehran, 1613566879, Iran

Homepage:  

Research Interests: Oral medicine, Oral cancer, Diagnostic techniques, Targeted therapies

Dr. Seyed Ali Mosaddad

E-mail: semosadd@ucm.es    

Affiliation: Department of Conservative Dentistry and Bucofacial Prosthesis, Faculty of Odontology, Complutense University of Madrid, Madrid, 28040, Spain.

Homepage:  

Research Interests: Prosthodontics, Implant Dentistry, Gerodontology, Digital Dentistry, Esthetic Dentistry

Summary

There have been several major technological advances in treating head and neck cancer. Immunotherapy, including checkpoint inhibitors and adoptive cell transplantation (ACT), helps the immune system recognize and attack cancer cells more effectively Targeted therapies, such as epidermal growth factor receptor inhibitors and molecular profiling, have become an integral part of personalized treatment plans and intensity modified intensity radiotherapy (IMRT). Proton- Radiation therapy like therapy reduces damage to surrounding healthy tissue. Robotic surgery, such as inter-robotic surgery (TORS), allows for the removal of less invasive tumors. Advanced imaging techniques, including positron emission tomography (PET) scans and functional MRI, improve the understanding of tumor localization and its effects on surrounding tissue Artificial intelligence and technology are used to study for the development of diagnostic tools and predictive analyses to assess cancer risk and treatment outcomes. Liquid biomarkers such as circulating tumor DNA (ctDNA) provide a noninvasive method for monitoring disease progression and response to therapy. Gene therapy and photodynamic therapy (PDT) are being investigated for possible treatments for head and neck cancer. Finally, patient-centered care, including multidisciplinary teams and telemedicine, ensures comprehensive and consistent patient care.

This special issue invites researchers and clinicians to contribute their original research articles and review articles. We are committed to fostering a platform for the exchange of innovative ideas and cutting-edge research that will propel the field forward. We welcome submissions that delve into the latest diagnostic and therapeutic advancements, aiming to improve the diagnostics and outcomes for head and neck cancer.   

Keywords